Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AORTIC 2017 /
Cancer staging in practice and research

7th - 10th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.11.17
Views: 966

Prof James Brierley - University of Toronto, Toronto, Canada

Prof Brierly speaks with ecancer at AORTIC 2017 about the utility of cancer staging, and misconceptions in their use.

He discusses how screening, registry interrogation and tracking shifting disease progression can give accurate insights into disease burden and outcome, noting that harmonised understanding prevents any miscommunication when comparing data across regions.

For more on cancer staging, watch Dr Max Parkin discuss UICC staging here.

For more on UICC TNM staging, ecancer provides an online training module here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation